Zooplus (ZO1.HM) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · Germany · ISIN DE0005111702
Zooplus financials
| Fiscal year | 2020 | 2021 |
|---|---|---|
| Revenue | 1.80 bn EUR | 0.00 EUR |
| Gross profit | 547.00 m EUR | 0.00 EUR |
| EBIT | 35.00 m EUR | 0.00 EUR |
| Net income | 18.00 m EUR | 0.00 EUR |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Zooplus
zooplus SE provides various pet supplies and products. It offers wet and dry food for dogs and cats; cages and hutches; bird food and cages; fish food and water care products; dog and cat vet and specialist food under the applaws, riantos, urms concept of life, cosma, encore, eukanuba, felix, furminator, hill's science plan, hill's prescription diet, IAMS, kooa, Lukullus, Modern Living, Natural Paradise, Nomad Tales, Pedigree, Porta 21, Purizon, Reel Belle, Rocco, Rosies, Farm, Royal Canin, Royal Canin Veterinary, Simpsons Premium, Smilla, Taste of the Wild, TIAKI, Tigerino, Whiskas, Wild Freedom, and Wolf of Wilderness brands. zooplus SE was founded in 1999 and is headquartered in Munich, Germany.
More stocks
- Gudang Garam Tbk (GGRM.JK)
- Grainger PLC (GRI.L)
- Shandong Pharmaceutical Glass Co Ltd (600529.SS)
- Eco-Shop Marketing Berhad (5337.KL)
- Prosegur Compania de Seguridad SA (PSG.MC)
- Hyundai Elevator (017800.KS)
- Aktor Holding Company Technical And Energy Projects SA (INKAT.AT)
- Hydsoft Technology Co. Ltd. A (301316.SZ)
- Maze Therapeutics, Inc. (MAZE)
- Cofoe Medical Technology Co.Ltd. (301087.SZ)
- ALAMO GROUP INC (ALG)
- NCC AB (NCC B.ST)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.